Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen in children with serious IUGR treated to final height
NCT01400698Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Nov 1998
- Primary completion
- Feb 2010
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of somatropin in intrauterine growth restriction (IUGR), sponsored by Merck KGaA. Started Nov 1998; status: completed.
02
Drugs
somatropin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NCT01400698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400698.